Status:

ACTIVE_NOT_RECRUITING

18F-DCFPyL Positron Emission Tomography (PET)/Computed Tomography (CT) in Men With Prostate Cancer

Lead Sponsor:

Columbia University

Conditions:

Prostatic Neoplasms

Eligibility:

MALE

18+ years

Phase:

PHASE2

PHASE3

Brief Summary

PyL, also known as \[18F\]DCFPyL, is a second-generation fluorinated prostate-specific membrane antigen (PSMA) targeted PET imaging agent. In preliminary studies it demonstrates a higher detection of ...

Detailed Description

The investigators will conduct a prospective phase II/III study of 300 men diagnosed with prostate cancer with a rising prostate-specific antigen (PSA). Upon enrollment, subjects will undergo standard...

Eligibility Criteria

Inclusion

  • Histologically confirmed diagnosis of prostate cancer
  • PSA ≥ 0.2ng/ml
  • Age ≥ 18 years of age
  • Eastern Cooperative Oncology Group (ECOG) performance status ≤ 2 (karnofsky ≥ 60%)
  • Ability to understand and willingness to sign a written informed consent document
  • Wiling to comply with clinical trial instructions and requirements
  • Willing to cover the cost of PyL PET/CT imaging if funds are not available

Exclusion

  • History of another active malignancy within 3 years, other than basal cell and squamous cell carcinoma of the skin
  • Presence of prostate brachytherapy implants unless approved by the PI
  • Administration of another radioisotope within five physical half-lives of trial enrollment
  • Radiation or chemotherapy within 2 weeks prior to trial enrollment
  • Serum creatinine \> 3 times the upper limit of normal
  • Serum total bilirubin \> 3 times the upper limit of normal
  • Aspartate transaminase (AST) or alanine aminotransferase (ALT) \>5 times the upper limit of normal
  • Inadequate venous access

Key Trial Info

Start Date :

February 12 2019

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 1 2023

Estimated Enrollment :

129 Patients enrolled

Trial Details

Trial ID

NCT03824275

Start Date

February 12 2019

End Date

December 1 2023

Last Update

May 11 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Columbia University Irving Medical Center

New York, New York, United States, 10032